These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 9571394

  • 1. Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers.
    Wiseman LR, Spencer CM.
    Drugs Aging; 1998 Apr; 12(4):305-34. PubMed ID: 9571394
    [Abstract] [Full Text] [Related]

  • 2. Docetaxel: an update of its use in advanced breast cancer.
    Figgitt DP, Wiseman LR.
    Drugs; 2000 Mar; 59(3):621-51. PubMed ID: 10776837
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel: a pharmacoeconomic review of its use in the treatment of ovarian cancer.
    Young M, Plosker GL.
    Pharmacoeconomics; 2001 Mar; 19(12):1227-59. PubMed ID: 11772158
    [Abstract] [Full Text] [Related]

  • 4. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB, Valero V, Hortobagyi G.
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.
    Vermorken JB.
    Int J Gynecol Cancer; 2001 Nov; 11 Suppl 1():21-30. PubMed ID: 11488999
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.
    Spencer CM, Faulds D.
    Drugs; 1994 Nov; 48(5):794-847. PubMed ID: 7530632
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of taxanes in the treatment of breast cancer.
    Capri G, Tarenzi E, Fulfaro F, Gianni L.
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [Abstract] [Full Text] [Related]

  • 12. Docetaxel in combination chemotherapy for metastatic breast cancer.
    Khayat D, Antoine E.
    Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evolution in the treatment of advanced breast cancer.
    Crown J.
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):12-7. PubMed ID: 9865706
    [Abstract] [Full Text] [Related]

  • 17. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
    Culy CR, Clemett D, Wiseman LR.
    Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.